Middlewich, United Kingdom

Andrew John Tummon


Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andrew John Tummon: Innovator in Infection Detection

Introduction

Andrew John Tummon is a notable inventor based in Middlewich, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of infections. With a total of 2 patents to his name, Tummon is recognized for his innovative approaches to healthcare technology.

Latest Patents

Tummon's latest patents focus on methods for detecting bacterial vaginosis. One patent describes a method for determining infections in liquid samples by detecting short-chain fatty acids and ammonia in the headspace associated with the liquid sample. This method involves lowering the pH of the liquid sample to drive short-chain fatty acids, particularly acetic acid, into the gaseous phase. The detection of these compounds is achieved using polymer sensors that are sensitive to short-chain fatty acids, ammonia, and optionally, amine species. The correlation of these detected substances with the presence of infection represents a significant advancement in diagnostic methods.

Career Highlights

Tummon is currently associated with Osmetech Plc, a company that specializes in innovative medical technologies. His work at Osmetech has allowed him to develop and refine his patented methods, contributing to the advancement of infection detection technologies.

Collaborations

Throughout his career, Tummon has collaborated with notable colleagues, including Paul James Travers and Amjad Nissar Chaudry. These collaborations have fostered a productive environment for innovation and development in the field of medical diagnostics.

Conclusion

Andrew John Tummon is a distinguished inventor whose work in infection detection has the potential to improve healthcare outcomes. His innovative patents and contributions to Osmetech Plc highlight his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…